studies on glp 1 Weight loss with GLP-1 medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans The Many Cardiovascular Benefits of

Combining GLP 1 medications with these glucose lowering agents substantially increases hypoglycemia risk

However, there are currently very few studies investigating the protective effects of GLP-1R agonists in the treatment of specifically glaucoma

Novo Nordisk (2018)

When the outer layer is evenly hydrated and composed, it reflects light more uniformlytexture looks smoother, tone looks more even, and the complexion reads cleaner and more controlled.

45 Additional studies confirmed that N-AcGIP, another long-acting GIP agonist, 46 decreased osteoclast-mediated bone resorption and enhanced cortical bone quality in rodents

That said, we do not treat peptides as casual add-ons or one-size-fits-all solutions